1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Chronic Heart Failure Global Clinical Trials Review, H2, 2014

Chronic Heart Failure Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Chronic Heart Failure Global Clinical Trials Review, H2, 2014" provides data on the Chronic Heart Failure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Heart Failure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Heart Failure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Chronic Heart Failure Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Chronic Heart Failure 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Chronic Heart Failure 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Chronic Heart Failure Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Chronic Heart Failure 33
Jul 08, 2014: CardioCell Begins Phase IIa Clinical Trial Using itMSC Therapy to Treat Chronic Heart Failure (HF) Due to Non-Ischemic Cardiomyopathy 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Zensun (Shanghai) Sci and Tech Co., Ltd. 34
Clinical Trial Overview of Zensun (Shanghai) Sci and Tech Co., Ltd. 34
Bayer AG 35
Clinical Trial Overview of Bayer AG 35
Orion Oyj 36
Clinical Trial Overview of Orion Oyj 36
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Les Laboratoires Servier SAS 38
Clinical Trial Overview of Les Laboratoires Servier SAS 38
Zambon Company S.p.A. 39
Clinical Trial Overview of Zambon Company S.p.A. 39
Takeda Pharmaceutical Company Limited 40
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 40
Galenica Ltd. 41
Clinical Trial Overview of Galenica Ltd. 41
F. Hoffmann-La Roche Ltd. 42
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 42
Alfred E. Tiefenbacher (GmbH and Co. KG) 43
Clinical Trial Overview of Alfred E. Tiefenbacher (GmbH and Co. KG) 43
Clinical Trial Overview of Top Institutes / Government 44
Institut de Recherches Internationales Servier 44
Clinical Trial Overview of Institut de Recherches Internationales Servier 44
Hull and East Yorkshire Hospitals NHS Trust 45
Clinical Trial Overview of Hull and East Yorkshire Hospitals NHS Trust 45
Fuwai Heart Hospital and Cardiovascular Institute 46
Clinical Trial Overview of Fuwai Heart Hospital and Cardiovascular Institute 46
St. Marianna University School of Medicine 47
Clinical Trial Overview of St. Marianna University School of Medicine 47
Federico II University 48
Clinical Trial Overview of Federico II University 48
University Health Network 49
Clinical Trial Overview of University Health Network 49
U.S. Department of Veterans Affairs 50
Clinical Trial Overview of U.S. Department of Veterans Affairs 50
Duke University 51
Clinical Trial Overview of Duke University 51
Medical University of Silesia 52
Clinical Trial Overview of Medical University of Silesia 52
Kobe University 53
Clinical Trial Overview of Kobe University 53
Five Key Clinical Trial Profiles 54
Appendix 100
Abbreviations 100
Definitions 100
Research Methodology 101
Secondary Research 101
About GlobalData 102
Contact Us 102
Disclaimer 102
Source 102

List of Tables
Chronic Heart Failure Therapeutics, Global, Clinical Trials by Region, 2014* 7
Chronic Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Chronic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Chronic Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Chronic Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Chronic Heart Failure Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Chronic Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Chronic Heart Failure Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Chronic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Chronic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Chronic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Chronic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Chronic Heart Failure Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Chronic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Chronic Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Chronic Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Chronic Heart Failure Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Chronic Heart Failure Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Chronic Heart Failure Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Chronic Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Chronic Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Chronic Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Chronic Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Chronic Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Zensun (Shanghai) Sci and Tech Co., Ltd., 2014* 34
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 35
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Orion Oyj, 2014* 36
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 37
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Les Laboratoires Servier SAS, 2014* 38
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Zambon Company S.p.A., 2014* 39
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 40
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Galenica Ltd., 2014* 41
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 42
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfred E. Tiefenbacher (GmbH and Co. KG), 2014* 43
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Recherches Internationales Servier, 2014* 44
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Hull and East Yorkshire Hospitals NHS Trust, 2014* 45
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Fuwai Heart Hospital and Cardiovascular Institute, 2014* 46
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Marianna University School of Medicine, 2014* 47
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Federico II University, 2014* 48
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2014* 49
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 50
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 51
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Silesia, 2014* 52
Chronic Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2014* 53

List of Figures
Chronic Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Chronic Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Chronic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Chronic Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Chronic Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Chronic Heart Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Chronic Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Chronic Heart Failure Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Chronic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Chronic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Chronic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Chronic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Chronic Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Chronic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Chronic Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Chronic Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Chronic Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Chronic Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Chronic Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Chronic Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Chronic Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 101

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...

Global Clinical Trials Market

December 2016 $ 4250

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.